FDA clears first NICU-friendly neonatal MRI system

The FDA has cleared an MRI system for head and brain imaging in neonatal intensive care units (NICUs).

The agency announced Thursday that Aspect Imaging’s Embrace Neonatal MRI system proved safe and efficacious in testing that included phantom image review by an independent board-certified radiologist.

FDA says the system, the first neonatal MRI to prove NICU-ready, uses a temperature-controlled incubator and enables removal of the baby from the scanner in fewer than 30 seconds in case of emergency.

Further, the Embrace system does not require a safety zone or a radiofrequency shielded room. The system is fully enclosed, allowing its use near people with medical implants that are not designated as MR-safe or -compatible, according to the announcement.

“Although we can use traditional MRI scanners to image neonates, taking babies outside of the neonatal intensive care unit to MRI suites presents great challenges,” says Vasum Peiris, MD, MPH, chief medical officer for pediatrics and special populations at FDA’s Center for Devices and Radiological Health, in prepared remarks. “Having a system in the neonatal intensive care enables safer imaging for this vulnerable patient population.”

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.

The new guidelines were designed to ensure sonographers and other members of the heart team have the information they need to screen patients when appropriate and identify early warnings signs of PH. 

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.